Clinical Trial Update: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AMG 151 on 24-hour ambulatory blood pressure and glucose levels in Type 2 diabetes subjects has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AMG 151

Snippet

Sponsor: Amgen | Conditions: Diabetes Mellitus | Phase 1 | Status: TERMINATED